Cyrona Cell Podcast: Stem Cell Therapy in Malaysia
Welcome to the Cyrona Cell Podcast, your trusted source for clear, doctor-led conversations about stem cell therapy and regenerative medicine in Malaysia.
Hosted by the team at Cyrona Cell in Kuala Lumpur, this podcast explores how mesenchymal stem cells (MSCs), exosome support, and evidence-informed cell-based care may help patients living with chronic inflammation, immune imbalance, and long-term degenerative conditions.
We discuss:
• How stem cell therapy works in real clinical settings
• What current research supports — and what it does not
• Eligibility and safety screening for treatment
• Conditions such as osteoarthritis, diabetes, neurological disorders, autoimmune diseases, and more
• What international patients can expect when seeking treatment in Malaysia
• Realistic outcomes, risks, and ethical standards in regenerative medicine
At Cyrona Cell, we believe in honest medicine — not hype. Every episode focuses on transparency, medical screening, patient suitability, and integrating cell therapy into a broader treatment plan.
If you are considering stem cell therapy in Kuala Lumpur and want medically grounded information before making a decision, this podcast is designed for you.
New episodes are released regularly.
Cyrona Cell Podcast: Stem Cell Therapy in Malaysia
Cell Therapy for Liver Cirrhosis: What Patients Should Know
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this episode, we explore the latest research on cell therapy for liver cirrhosis and what patients should understand before considering emerging treatment options. A new 2026 study on autologous macrophage therapy has generated excitement, but it’s important to separate promising research from unproven claims.
You’ll learn:
- What liver cirrhosis is and why advanced scarring is difficult to treat
- How autologous macrophage therapy works and why it differs from traditional stem cell therapies
- The key findings from the MATCH trial and its long-term follow-up results
- Why transplant-free survival is an important measure for cirrhosis patients
- The difference between experimental clinical research and commercially marketed cell therapies
- What regulators and liver specialists say about unapproved stem cell clinics
- How macrophage therapy compares with mesenchymal stem cell (MSC) research
- The questions patients should ask before considering any cell-based treatment
- Why evidence-based care and ongoing medical supervision remain essential
Whether you are living with liver cirrhosis, researching regenerative medicine, or following developments in cell therapy, this episode provides a balanced look at the science, the limitations, and the potential future of liver disease treatment.
Blog Link: Cell Therapy for Liver Cirrhosis: What Patients Should Know